Smith+Nephew closes acquisition of CartiHeal
Smith & Nephew PLC (LSE:SN) said today that it has closed the acquisition of CartiHeal, an Israel-based developer of sports medicine technology for cartilage regeneration in the knee. The medical ...
Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
Smith & Nephew shares are down 3.6% since February, but management has increased top-line growth guidance for fiscal 2022. The Orthopedics business unit is showing strong growth potential, with mom...
Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite
Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.
Smith & Nephew acquires cartilage regeneration firm
Smith & Nephew PLC (LSE:SN) has announced the acquisition of knee cartilage regeneration technology developer CartiHeal. Under the agreement, the FTSE 100-listed medical equipment manufacturer will...
Smith & Nephew's underperformance set to change, says Goldman
Smith & Nephew PLC (LSE:SN)'s underperformance is set to change, according to Goldman Sachs (NYSE:GS). The investment bank has initiated coverage of the medical technology outfit with a buy rating ...
Smith & Nephew plc (SNN) Q3 2023 Earnings Call Transcript
Smith & Nephew plc (NYSE:SNN ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Office...
Smith & Nephew downgrade cycle coming to an end
JPMorgan has upgraded the firm to overweight from neutral pointing out shares have de-rated to 10-year lows in recent weeks. This reflected concerns on a margin guidance downgrade post-H1 soft marg...
Smith & Nephew shares up 4.2% on FY sales upgrade
Shares in Smith & Nephew PLC (LSE:SN) surged by 4.2% as the company projected sales growth to hit the upper end of its guidance following a robust third quarter, despite a slight tempering of margi...
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
Smith & Nephew (SNN) Loses -5.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Smith & Nephew (SNN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in r...
Related Companies